title: Treatment of human myasthenia gravis with oral antisense suppression of acetylcholinesterase.
authors: Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. zargov@md2.huji.ac.il
authors: Z
authors: Z
authors: Argov
authors: D
authors: D
authors: McKee
authors: S
authors: S
authors: Agus
authors: S
authors: S
authors: Brawer
authors: N
authors: N
authors: Shlomowitz
authors: O Ben
authors: OB
authors: Yoseph
authors: H
authors: H
authors: Soreq
authors: J D
authors: JD
authors: Sussman
mesh_terms: D000110:Acetylcholinesterase / Q000378:metabolism; D000284:Administration, Oral; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage*; D006801:Humans; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000201:enzymology*; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage*
chemical_list: D002800:Cholinesterase Inhibitors; D016376:Oligonucleotides, Antisense; D000110:Acetylcholinesterase